Physical Activity and Fitbit for Reducing Cannabis Use During Pregnancy
Trial Summary
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. However, it does mention that participants should not have started a new form of mental health or substance use treatment within the past 4 weeks.
What data supports the effectiveness of the treatment Fitbit-Based Physical Activity Intervention for reducing cannabis use during pregnancy?
There is no direct evidence from the provided research articles about the effectiveness of Fitbit-Based Physical Activity Intervention for reducing cannabis use during pregnancy. However, one study suggests that physical activity can be a useful intervention target for cannabis use, indicating potential utility in this context.12345
Is using a Fitbit-based physical activity intervention generally safe for humans?
How does the LPA+Fitbit treatment differ from other treatments for reducing cannabis use during pregnancy?
The LPA+Fitbit treatment is unique because it combines lifestyle physical activity with the use of a Fitbit, a wearable device that tracks physical activity, to help reduce cannabis use during pregnancy. This approach leverages the motivational and tracking capabilities of the Fitbit to encourage increased physical activity, which is not a standard treatment for cannabis use during pregnancy.910111213
What is the purpose of this trial?
The overall goal of this pilot study is to develop and preliminarily evaluate an LPA intervention designed to reduce cannabis use during pregnancy.
Research Team
Cynthia Battle, PhD
Principal Investigator
Butler Hospital
Eligibility Criteria
This trial is for pregnant women over 18, between 12-25 weeks along with a healthy pregnancy, who use cannabis weekly and want to stop. They must be cleared for exercise by their doctor, not meet current physical activity guidelines, experience some psychological distress, speak English, own a smartphone for the Fitbit app, and have an interest in reducing cannabis use.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants are randomly assigned to either a LPA+Fitbit intervention or Fitbit Only control condition for 12 weeks
Follow-up
Participants are monitored for safety and effectiveness after treatment, with assessments extending to the end of pregnancy and into the postpartum period
Postpartum Monitoring
Birth record abstractions to collect information about specific outcomes such as pre-term delivery and low birth weight
Treatment Details
Interventions
- Fitbit Only
- LPA+Fitbit Intervention
Find a Clinic Near You
Who Is Running the Clinical Trial?
Butler Hospital
Lead Sponsor